Vira Regen Competitors and Similar CompaniesClear all

Vira Regen's competitors and similar companies include CureVac, AnaptysBio and Biocon.

	Vira Regen Vira Regen is a regenerative biotech company that specializes in gene-specific electroceuticals.	CureVac CureVac is a biotechnology company offering messenger RNA (mRNA) technology.	AnaptysBio AnaptysBio is a biotechnology company developing immunology therapeutic product candidates.	Biocon Biocon is a company that develops and manufactures biopharmaceutical products.
Founding Date	Founding Date 2023	Founding Date 2000	Founding Date 2005	Founding Date 1978
Type	Type Private	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech drug development oncology	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development pharma
Locations	Locations Salt Lake City, US HQ	Locations Tübingen, DE HQ Ottignies Louvain La Neuve, BE Wiesbaden, DE Amsterdam, NL Basel, CH Boston, US	Locations San Diego, US HQ San Diego, US	Locations Bengaluru, IN HQ Bengaluru, IN Nanakramguda, IN Dublin, IE Kuala Lumpur, MY Puchong, MY Delémont, CH see more
Employees	Employees 3	Employees 82517% decrease	Employees 898% decrease	Employees 16,5612% increase
Valuation ($)	Valuation ($) N/A	Valuation ($) 648.3 m	Valuation ($) 930.2 m	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) €535.2m (FY, 2024)	Revenue (est.) $234.6m (FY, 2025)	Revenue (est.) ₹167.8b (FY, 2026)
Cost of goods	Cost of goods N/A	Cost of goods €9.7m (FY, 2024)	Cost of goods N/A	Cost of goods ₹56.9b (FY, 2026)
Gross profit	Gross profit N/A	Gross profit €534.4m (FY, 2024)	Gross profit N/A	Gross profit ₹115.8b (FY, 2026)
Net income	Net income N/A	Net income €162.2m (FY, 2024)	Net income N/A	Net income ₹3.7b (FY, 2026)
Funding
Total funding raised	Total funding raised N/A	Total funding raised $ 1.1b	Total funding raised $ 83.9m	Total funding raised N/A